Latest Breaking News On - Eli lilly mounjaro zepbound - Page 1 : comparemela.com

Cipla keen on obesity segment, to bring out products on its own or though partnership

Cipla keen on obesity segment, to bring out products on its own or though partnership
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

South africaUnited statesNovo nordisk wegovy ozempicEli lilly mounjaro zepboundEli lillyUmang vohraCipla managing directorGlobal chief executive officerNovo nordiskNorth america

weight-loss drugs: Dr Reddy s, Sun, Cipla and Biocon look to recreate Ozempic magic in India

Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resort for some. “I would rather go for these short cuts that the pharma industry offers than go under the knife for my appearance,” says Rajput. The drugs — Wegovy and Ozempic — which have the same ingredient, semaglutide, are all the rage ever since entrepreneur Elon Musk tweeted about it.

United kingdomAmbrish mithalEli lillyAnoop misraEli lilly mounjaro zepboundShivali rajputDavid ricksElon muskDrug administrationExpert committeeCentre of excellenceSun pharmaceutical industriesNovo nordiskCentral drugs standard control organisationMetabolic diseasesMight also like

weight loss: Eli Lilly in advanced clinical trials for its weight-loss pill

Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with type-two diabetes and obesity or overweight at an increased cardiovascular risk. The company s spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron.

Andhra pradeshEli lilly mounjaro zepboundEli lillyDavid ricksNovo nordiskWeight lossWeight loss pillClinical trials